| Pars plana capsulotomy in the treatment of posterior capsule opacifications | Mustafa DURMUŞ,Yusuf ÖZERTÜRK,Yavuz BARDAK | 104–106 |
| Our penetrating keratoplasty results | Selim DOĞANAY,Mehmet BAHADIR,Ömer Kamil DOĞAN | 107–109 |
| Disposable daily wear contact lenses | Sibel COŞKUN,Ayfer KANPOLAT | 110–112 |
| The correlation between cup to disc ratio and visual field defect in primary open angle glaucoma | Volkan YAYLALI,Cem YILDIRIM,Tamer ARIKAN,Serap ÖZDEN | 113–115 |
| Increased intraocular pressure in patients with uveitis | Yüksel SÜLLÜ,İhsan ÖGE,Fatma ÖGE,Nurşen ARITÜRK,Dilek ERKAN | 116–119 |
| Selective laser trabeculoplasty: Early clinical results | Umur KAYHAN,Tülay TUNA,Gültekin KÖKLÜ,Akdeniz Belma KAYHAN,Metin ÜNAL,Erdal GEDAR,Esin FIRAT | 120–122 |
| The evaluation of short-term effect of combined therapy with latanoprost and betaxolol on intraocular pressure | Mustafa Kemal ARICI,Aysen TOPALKARA,Cenap GÜLER,Haydar ERDOĞAN | 123–126 |
| Comparison of ocular irritation levels after topical beta blocker usage | Ahmet AKMAN,Volkan YAYLALI,Melih ÜNAL,Murat SÖNMEZ,Yavuz ÖRGE | 127–130 |
| Refractive status and axial length in branch retinal vein occlusion | Gamze MEN,Melih AKBAŞ,Alaeddin DURMAZ,Sonar Seyhan ÖZKAN,Atilla Halil ELHAN,Emel SOYKAN,Orhan ZİLELİOĞLU | 131–133 |
| Factor V Leiden and prothrombin 20210 A mutations in patients with retinal vein occlusion | DEFNE KALAYCI,Aytemiz GÜRGEY,Dilek GÜVEN,Hikmet HASIRİPİ | 134–136 |
| Serum IgA concentrations in patients with type II diabetes mellitus with proliferative and nonproliferative diabetic retinopathy | Ayhan SÜRÜCÜ,Mucize YARARCAN,Yeşim ATEŞ,Filiz AKYOL | 137–140 |
| Correlation between serum lipoprotein (a) levels and diabetic retinopathy in patients with type II diabetes mellitus | Fatma OKTAY,Mucize YARARCAN,Yeşim ATEŞ,Can Safiye KÜÇÜKGÜL,Nazife SEFİ | 141–144 |
|